Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 575

The DOI matches its Crossref record.

Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies

·2007·The Lancet

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(07)61684-5

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 66

  1. Cogliano, 2005, Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment, Lancet Oncol, 6, 552, 10.1016/S1470-2045(05)70273-4 · DOI · Paper page
  2. Smith, 2003, Cervical cancer and use of hormonal contraceptives: a systematic review, Lancet, 361, 1159, 10.1016/S0140-6736(03)12949-2 · DOI · Paper page
  3. 2006, Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13 541 women with carcinoma of the cervix and 23 017 women without carcinoma of the cervix from 23 epidemiological studies, Int J Cancer, 118, 1481, 10.1002/ijc.21493 · DOI · Paper page
  4. 2006, Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16 563 women with cervical cancer and 33 542 women without cervical cancer from 25 epidemiological studies, Int J Cancer, 119, 1108, 10.1002/ijc.21953 · DOI · Paper page
  5. 2007, Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8097 women with squamous cell carcinoma and 1374 women with adenocarcinoma from 12 epidemiological studies, Int J Cancer, 120, 885, 10.1002/ijc.22357 · DOI · Paper page
  6. Ngelangel, 1998, Causes of cervical cancer in the Philippines: a case-control study, J Natl Cancer Inst, 90, 43, 10.1093/jnci/90.1.43 · DOI · Paper page
  7. Chichareon, 1998, Risk factors for cervical cancer in Thailand: a case-control study, J Natl Cancer Inst, 90, 50, 10.1093/jnci/90.1.50 · DOI · Paper page
  8. Sitas, 2000, The spectrum of HIV-1 related cancers in South Africa, Int J Cancer, 88, 489, 10.1002/1097-0215(20001101)88:3<489::AID-IJC25>3.0.CO;2-Q · DOI · Paper page
  9. Munoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med, 348, 518, 10.1056/NEJMoa021641 · DOI · Paper page
  10. 2003, Breast cancer and hormone-replacement therapy in the Million Women Study, Lancet, 362, 419, 10.1016/S0140-6736(03)14065-2 · DOI · Paper page
  11. Zondervan, 1996, Oral contraceptives and cervical cancer—further findings from the Oxford Family Planning Association contraceptive study, Br J Cancer, 73, 1291, 10.1038/bjc.1996.247 · doi:10.1038/bjc.1996.247
  12. Plummer, 2004, Improved estimates of floating absolute risk, Stat Med, 23, 93, 10.1002/sim.1485 · DOI · Paper page
  13. Kjaer, 1996, Human papillomavirus-the most significant risk determinant of cervical intraepithelial neoplasia, Int J Cancer, 65, 601, 10.1002/(SICI)1097-0215(19960301)65:5<601::AID-IJC8>3.0.CO;2-6 · DOI · Paper page
  14. Hildesheim, 2001, HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica, Br J Cancer, 84, 1219, 10.1054/bjoc.2001.1779 · DOI · Paper page
  15. Deacon, 2000, Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort, Br J Cancer, 83, 1565, 10.1054/bjoc.2000.1523 · DOI · Paper page
  16. Schiffman, 1993, Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia, J Natl Cancer Inst, 85, 958, 10.1093/jnci/85.12.958 · DOI · Paper page
  17. Beral, 1988, Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners' Oral Contraception Study, Lancet, 2, 1331, 10.1016/S0140-6736(88)90869-0 · DOI · Paper page
  18. Ylitalo, 1999, Smoking and oral contraceptives as risk factors for cervical carcinoma in situ, Int J Cancer, 81, 357, 10.1002/(SICI)1097-0215(19990505)81:3<357::AID-IJC8>3.0.CO;2-1 · DOI
  19. Gram, 1992, Oral contraceptive use and the incidence of cervical intraepithelial neoplasia, Am J Obstet Gynecol, 167, 40, 10.1016/S0002-9378(11)91622-6 · doi:10.1016/s0002-9378(11)91622-6
  20. Brinton, 1986, Long-term use of oral contraceptives and risk of invasive cervical cancer, Int J Cancer, 38, 399, 10.1002/ijc.2910380307 · doi:10.1002/ijc.2910380307
  21. Jones, 1990, Risk factors for in situ cervical cancer: results from a case-control study, Cancer Res, 50, 3657
  22. Daling, 1996, The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection, Cancer Epidemiol Biomarkers Prev, 5, 541
  23. Madeleine, 2001, Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix, Cancer Epidemiol Biomarkers Prev, 10, 171
  24. Bosch, 1992, Risk factors for cervical cancer in Colombia and Spain, Int J Cancer, 52, 750, 10.1002/ijc.2910520514 · DOI · Paper page
  25. Cuzick, 1990, Case-control study of risk factors for cervical intraepithelial neoplasia in young women, Eur J Cancer, 26, 684, 10.1016/0277-5379(90)90117-C · DOI
  26. Ursin, 1994, Oral contraceptive use and adenocarcinoma of cervix, Lancet, 344, 1390, 10.1016/S0140-6736(94)90567-3 · DOI
  27. Ursin, 1996, Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States), Cancer Causes Control, 7, 391, 10.1007/BF00052946 · doi:10.1007/bf00052946
  28. Peters, 1986, Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County, J Natl Cancer Inst, 77, 1063
  29. Kjaer, 1993, Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use, Cancer Causes Control, 4, 513, 10.1007/BF00052426 · doi:10.1007/bf00052426
  30. Cuzick, 1996, Risk factors for invasive cervix cancer in young women, Eur J Cancer, 32A, 836, 10.1016/0959-8049(95)00650-8 · DOI
  31. Green, 2003, Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years: the UK National Case-Control study of Cervical Cancer, Br J Cancer, 89, 2078, 10.1038/sj.bjc.6601296 · DOI
  32. Lacey, 1999, Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas, Cancer Epidemiol Biomarkers Prev, 8, 1079
  33. Thomas, 2001, Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas, Am J Epidemiol, 153, 732, 10.1093/aje/153.8.732 · DOI
  34. Brinton, 1990, Oral contraceptive use and risk of invasive cervical cancer, Int J Epidemiol, 19, 4, 10.1093/ije/19.1.4 · DOI
  35. Herrero, 1990, Injectable contraceptives and risk of invasive cervical cancer: evidence of an association, Int J Cancer, 46, 5, 10.1002/ijc.2910460103 · doi:10.1002/ijc.2910460103
  36. Hammouda, 2005, Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors, Int J Cancer, 113, 483, 10.1002/ijc.20600 · DOI
  37. Eluf-Neto, 1994, Human papillomavirus and invasive cervical cancer in Brazil, Br J Cancer, 69, 114, 10.1038/bjc.1994.18 · DOI · Paper page
  38. Santos, 2001, HPV types and cofactors causing cervical cancer in Peru, Br J Cancer, 85, 966, 10.1054/bjoc.2001.1948 · DOI
  39. Munoz, 1993, Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia, Cancer Epidemiol Biomarkers Prev, 2, 423
  40. Chaouki, 1998, The viral origin of cervical cancer in Rabat, Morocco, Int J Cancer, 75, 546, 10.1002/(SICI)1097-0215(19980209)75:4<546::AID-IJC9>3.0.CO;2-T · DOI
  41. Rolón, 2000, Human papillomavirus infection and invasive cervical cancer in Paraguay, Int J Cancer, 85, 486, 10.1002/(SICI)1097-0215(20000215)85:4<486::AID-IJC7>3.0.CO;2-S · DOI
  42. Bayo, 2002, Risk factors of invasive cervical cancer in Mali, Int J Epidemiol, 31, 202, 10.1093/ije/31.1.202 · DOI · Paper page
  43. Franceschi, 2003, Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study, Int J Cancer, 107, 127, 10.1002/ijc.11350 · DOI · Paper page
  44. Parazzini, 1998, Time since last use of oral contraceptives and risk of invasive cervical cancer, Eur J Cancer, 34, 884, 10.1016/S0959-8049(97)10139-3 · doi:10.1016/s0959-8049(97)10139-3
  45. Parazzini, 1988, Risk factors for adenocarcinoma of the cervix: a case-control study, Br J Cancer, 57, 201, 10.1038/bjc.1988.43 · DOI
  46. Parazzini, 1992, Risk factors for cervical intraepithelial neoplasia, Cancer, 69, 2276, 10.1002/1097-0142(19920501)69:9<2276::AID-CNCR2820690912>3.0.CO;2-Q · doi:10.1002/1097-0142(19920501)69:9<2276::aid-cncr2820690912>3.0.co;2-q
  47. 1992, Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Contraception, 45, 299, 10.1016/0010-7824(92)90052-U · DOI
  48. 1993, Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study. WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Int J Cancer, 55, 228, 10.1002/ijc.2910550211 · doi:10.1002/ijc.2910550211
  49. Ye, 1995, Combined oral contraceptives and risk of cervical carcinoma in situ. WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Int J Epidemiol, 24, 19, 10.1093/ije/24.1.19 · doi:10.1093/ije/24.1.19
  50. Thomas, 1995, Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Contraception, 52, 307, 10.1016/0010-7824(95)00215-V · DOI
  51. Thomas, 1995, Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA). WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Contraception, 51, 25, 10.1016/0010-7824(94)00007-J · DOI
  52. Thomas, 1996, Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives, Am J Epidemiol, 144, 281, 10.1093/oxfordjournals.aje.a008923 · doi:10.1093/oxfordjournals.aje.a008923
  53. Boyce, 1977, Oral contraceptives and cervical carcinoma, Am J Obstet Gynecol, 128, 761, 10.1016/0002-9378(77)90717-7 · doi:10.1016/0002-9378(77)90717-7
  54. Celentano, 1987, The role of contraceptive use in cervical cancer: the Maryland Cervical Cancer Case-Control Study, Am J Epidemiol, 126, 592, 10.1093/oxfordjournals.aje.a114699 · DOI
  55. Ebeling, 1987, Use of oral contraceptives and risk of invasive cervical cancer in previously screened women, Intl J Cancer, 39, 427, 10.1002/ijc.2910390402 · doi:10.1002/ijc.2910390402
  56. Hsieh, 1999, Reproductive and infectious risk factors for invasive cervical cancer in Taiwan, Anticancer Res, 19, 4495
  57. Irwin, 1988, Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association?, JAMA, 259, 59, 10.1001/jama.1988.03720010037037 · doi:10.1001/jama.1988.03720010037037
  58. Lazcano-Ponce, 1995, Reproductive risk factors and sexual history associated with cervical cancer in Mexico, Revista de Investigacion Clinica, 47, 377
  59. Melamed, 1969, Prevalence rates of uterine cervical carcinoma in situ for women using the diaphragm or contraceptive oral steroids, BMJ, 3, 195, 10.1136/bmj.3.5664.195 · doi:10.1136/bmj.3.5664.195
  60. Slattery, 1989, Sexual activity, contraception, genital infections, and cervical cancer: support for a sexually transmitted disease hypothesis, Am J Epidemiol, 130, 248, 10.1093/oxfordjournals.aje.a115331 · DOI
  61. Talbott, 1995, Refining preventive strategies for invasive cervical cancer: a population-based case-control study, J Women's Health, 4, 387, 10.1089/jwh.1995.4.387 · doi:10.1089/jwh.1995.4.387
  62. Worth, 1972, A case control study into the possible effects of birth control pills on pre-clinical carcinoma of the cervix, J Obstet Gynaecol Br Commonw, 79, 673, 10.1111/j.1471-0528.1972.tb12899.x · doi:10.1111/j.1471-0528.1972.tb12899.x
  63. Shapiro, 2003, Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa), Cancer Causes Control, 14, 485, 10.1023/A:1024910808307 · DOI
  64. 1996, Breast cancer and hormonal contraceptives: further results, Contraception, 54, 13S
  65. Schiffman, 2003, Natural history of anogenital human papillomavirus infection and neoplasia, J Natl Cancer Inst Monogr, 31, 14, 10.1093/oxfordjournals.jncimonographs.a003476 · DOI · Paper page
  66. Yang, 2004, Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost, Int J Cancer, 109, 418, 10.1002/ijc.11719 · DOI · Paper page

Cited by

See all 575

Metadata

Venue
The Lancet
Publisher
Elsevier BV
Published
2007-11
Volume
370
Issue
9599
Pages
1609-1621
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W1664871341
Cited by
575
References
0
FWCI
17.17
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies. https://app.cochat.ai/papers/10.1016/s0140-6736(07)61684-5
The paper
Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies. (2007). The Lancet. https://doi.org/10.1016/s0140-6736(07)61684-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.